Shanghai Kehua Bio-engineering Co Ltd Class A 002022
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 6.52
- Day Range
- CNY 6.51–6.75
- 52-Week Range
- CNY 6.19–11.85
- Bid/Ask
- CNY 6.66 / CNY 6.67
- Market Cap
- CNY 3.43 Bil
- Volume/Avg
- 4.3 Mil / 5.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 3.91
- Price/Sales
- 1.68
- Dividend Yield (Trailing)
- 9.01%
- Dividend Yield (Forward)
- —
- Total Yield
- 9.20%
Company Profile
Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,151
- Website
- http://www.skhb.com
Comparables
Valuation
Metric
|
002022
|
300463
|
301060
|
---|---|---|---|
Price/Earnings (Normalized) | 3.91 | 24.36 | 30.20 |
Price/Book Value | 0.84 | 1.22 | 2.20 |
Price/Sales | 1.68 | 2.77 | 2.30 |
Price/Cash Flow | — | 10.61 | 8.75 |
Price/Earnings
002022
300463
301060
Financial Strength
Metric
|
002022
|
300463
|
301060
|
---|---|---|---|
Quick Ratio | 3.45 | — | 2.50 |
Current Ratio | 4.78 | — | 3.03 |
Interest Coverage | −3.95 | — | −18.88 |
Quick Ratio
002022
300463
301060
Profitability
Metric
|
002022
|
300463
|
301060
|
---|---|---|---|
Return on Assets (Normalized) | −5.11% | 4.64% | −5.18% |
Return on Equity (Normalized) | −8.33% | 6.05% | −8.53% |
Return on Invested Capital (Normalized) | −5.79% | 5.41% | −6.57% |
Return on Assets
002022
300463
301060
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Stbdrhmy | Khvbfq | $175.2 Bil | |
SYK
| Stryker Corp | Dwtjjmskf | Zvzlb | $127.8 Bil | |
BSX
| Boston Scientific Corp | Gckkrcrq | Hgmkv | $110.3 Bil | |
MDT
| Medtronic PLC | Bnrwkrz | Vcxpw | $105.7 Bil | |
EW
| Edwards Lifesciences Corp | Ghphrqhcj | Xwcjlz | $53.0 Bil | |
DXCM
| DexCom Inc | Synjndpy | Mtjc | $50.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Xqyqwxv | Pyqjp | $25.6 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Bdkyhlymql | Wqzhn | $23.7 Bil | |
ALGN
| Align Technology Inc | Njgktppr | Hkzgtn | $19.3 Bil | |
PODD
| Insulet Corp | Fjgvbbzzmz | Xxhwn | $12.1 Bil |